Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub

The Novo Nordisk Foundation, part of the Danish pharma Novo Group, is stumping up $47.5 million for a new research collab between the Broad Institute of MIT and Harvard.